Key Record Dates
ClinicalTrials.gov Identifier: | NCT02161679 |
---|---|
Brief Title: | Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer |
First Submitted : | June 10, 2014 |
First Submitted that Met QC Criteria : | June 11, 2014 |
First Posted : | June 12, 2014 (Estimate) |
Last Update Submitted that Met QC Criteria : | October 9, 2015 |
Last Update Posted : | October 12, 2015 (Estimate) |